NCT03401294View on ClinicalTrials.gov

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

PHASE2RecruitingINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG

FOLFOXIRI and Bevacizumab

Every 2 week for a total of 12 cycles

Trial Locations (1)

Unknown

RECRUITING

Allan Balir Cancer Center, Regina

All Listed Sponsors

lead

University of Saskatchewan

OTHER